VH032 thiol is primarily utilized in the field of chemical biology and drug discovery, particularly in the development of proteolysis-targeting chimeras (PROTACs). These molecules are designed to degrade specific proteins within cells, offering a novel approach to treating diseases such as cancer. VH032 thiol serves as a key component in the synthesis of PROTACs by enabling the recruitment of E3 ubiquitin ligases, which are essential for the targeted protein degradation process. Its application extends to the study of protein-protein interactions and the exploration of new therapeutic strategies, making it a valuable tool in advancing precision medicine.